Refresh

Gland Pharma Ltd. - Research Center

543245 GLAND Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

3,616.53 4,400.71 3,462.88 2,633.24 2,044.20
Expenses

Material consumed

1,733.32 2,149.33 1,538.17 1,136.27 883.30

Manufacturing expenses

124.84 95.05 74.59 78.50 74.03

Personnel expenses

399.70 338.57 311.36 277.66 222.95

Selling expenses

7.79 2.02 1.95 5.19 4.21

Adminstrative expenses

332.34 305.10 234.54 180.15 153.41

Expenses capitalised

- - - - -

Cost of sales

2,597.98 2,890.07 2,160.61 1,677.77 1,337.89

Operating profit

1,018.55 1,510.64 1,302.27 955.47 706.31

Other recurring income

240.46 223.94 134.78 139.17 85.56

Adjusted PBDIT

1,259.01 1,734.58 1,437.04 1,094.64 791.88

Financial expenses

7.41 5.24 3.41 7.18 3.56

Depreciation

146.74 110.30 98.78 94.59 81.96

Other write offs

- - - - -

Adjusted PBT

1,104.86 1,619.04 1,334.85 992.87 706.36

Tax charges

272.58 406.89 337.85 220.01 234.45

Adjusted PAT

832.29 1,212.16 997.01 772.86 471.91

Non recurring items

-56.46 - - - -20.00

Other non cash adjustments

- - - - -

Reported net profit

775.83 1,212.16 997.01 772.86 451.91

Earnigs before appropriation

6,010.70 5,234.88 4,022.72 3,025.72 2,252.86

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

6,010.70 5,234.88 4,022.72 3,025.72 2,252.86
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com